Viswanath Gunda

CDK4/6 Inhibition Augments Antitumor Immunity by Enhancing T-cell Activation

Jiehui Deng, Eric S. Wang, Russell W. Jenkins et al. · Cancer Discovery · 2017 · 741 citations · Full text

<i>Ex Vivo</i> Profiling of PD-1 Blockade Using Organotypic Tumor Spheroids

Russell W. Jenkins, Amir Reza Aref, Patrick H. Lizotte et al. · Cancer Discovery · 2017 · 552 citations · Full text

Transcription factor Nrf2 regulates SHP and lipogenic gene expression in hepatic lipid metabolism

Jiansheng Huang, Iméne Tabbi‐Anneni, Viswanath Gunda et al. · American Journal of Physiology-Gastrointestinal and Liver Physiology · 2010 · 227 citations · Full text

Nrf2 Deficiency, Fatty Liver Disease, Oxidative Stress +21

Anti-androgenic endocrine disrupting activities of chlorpyrifos and piperophos

Viswanath Gunda, Shamba Chatterjee, Swati Dabral et al. · The Journal of Steroid Biochemistry and Molecular Biology · 2010 · 111 citations

Endocrine Disruptors, Biochemistry, Endocrine Mechanism +5

Anti‐PD‐1/PD‐L1 therapy augments lenvatinib's efficacy by favorably altering the immune microenvironment of murine anaplastic thyroid cancer

Viswanath Gunda, Benjamin J. Gigliotti, Tameem Ashry et al. · International Journal of Cancer · 2018 · 108 citations · Full text

Immune Microenvironment, Pmn‐mdsc Expansion, Immunology +19